Embla Medical hf (LTS:0FIW)
kr 35.8 0 (0%) Market Cap: 15.97 Bil Enterprise Value: 19.22 Bil PE Ratio: 32.52 PB Ratio: 2.92 GF Score: 77/100

Q3 2024 Embla Medical hf Earnings Call Transcript

Oct 22, 2024 / 07:00AM GMT
Release Date Price: kr29.9
Sveinn SÃ;lvason
Embla Medical hf - President and Chief Executive Officer

¶ -

Good morning, and welcome to the Embla Medical conference call where we will review the third quarter results for 2024. I'm [Sveinn] Solvason, CEO of Embla Medical and joining the joining me today here from Copenhagen is our Chief Financial Officer, Arna Sveinsdottir and Embla Medical's Head of Investor Relations, Klaus Sindahl.

Today we'll discuss the financial performance and progress we've made during the third quarter. The presentation should take roughly 15 minutes after which there will be an opportunity to ask questions during a Q&A session.

If you go to the next slide please, we continue to deliver solid growth. Organic sales growth was 7% and local currency growth was 11% including an impact from M&A and currency. We continue to see a strong momentum in the EMEA driven by prosthetics and neuro products as well as patient care. Our pricing and support business, however, delivered a more modest growth for the quarter.

Our EBITDA margin came in strong at 22% supported by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot